Market Overview

Emergent Biosolutions, Inc. (NYSE: EBS)

54.32 +2.26 (4.34%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/12/19GuggenheimInitiates Coverage OnBuy65.0
9/04/19Wells FargoUpgradesOutperform64.0
11/02/18Cantor FitzgeraldMaintainsOverweight75.0
11/02/18Goldman SachsUpgradesBuy75.0
9/04/18Chardan CapitalMaintainsBuy66.0
8/30/18Wells FargoMaintainsMarket Perform65.0
6/13/18ArgusInitiates Coverage OnBuy62.0
6/12/18Cantor FitzgeraldInitiates Coverage OnOverweight62.0
4/25/18Wells FargoDowngradesMarket Perform
2/27/18Singular ResearchMaintainsBuy60.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter